This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 patients affected by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) shifted from intravenous to subcutaneous immunoglobulin treatment. A therapeutic shift from intravenous to subcutaneous immunoglobulin was performed in 87 patients (66 CIDP; 21 MMN) affected by immune-mediated peripheral neuropathies with evidence of a sustained clinical response to intravenous immunoglobulin. Patients were evaluated by means of the Overall Neuropathy Limitation Scale, Medical Research Council Scale and Life Quality Index questionnaire, both at the time of therapeutic shift and after 4 months of subcutaneous immunoglobulin treatment. A sustained clinical efficacy was observed after the switch to subcutaneous immunoglobulin: the Overall Neuropathy Limitation Scale score improved in the group of 66 CIDP patients (P = 0.018), with only one subject reporting a worsening of 1 point, and remained stable in the group of 21 MMN patients (P = 0.841), with one subject reporting a worsening of two points. An improvement in the patient's perception of therapeutic setting was reported in both groups. This large multi-center study confirms the short-term clinical equivalence of subcutaneous versus intravenous immunoglobulin and a possible improvement in the patient's perception of therapeutic setting with the subcutaneous administration. However, further studies are required to extend the results to a longer observational period. © 2014 Springer-Verlag Berlin Heidelberg.

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study / Dario, Cocito; Aristide, Merola; Erdita, Peci; Anna, Mazzeo; Raffaella, Fazio; Francia, Ada; Paola, Valentino; Rocco, Liguori; Massimiliano, Filosto; Gabriele, Siciliano; Angelo Maurizio, Clerici; Stefania, Lelli; Girolama Alessandra, Marfia; Antonini, Giovanni; Ilaria, Cecconi; Eduardo Nobile, Orazio; Leonardo, Lopiano; Italian Network Scig And chronic Dysimmune, Neuropathies. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - STAMPA. - 261:(2014), pp. 2159-2164. [10.1007/s00415-014-7444-2]

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study

FRANCIA, Ada;ANTONINI, Giovanni;
2014

Abstract

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 patients affected by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) shifted from intravenous to subcutaneous immunoglobulin treatment. A therapeutic shift from intravenous to subcutaneous immunoglobulin was performed in 87 patients (66 CIDP; 21 MMN) affected by immune-mediated peripheral neuropathies with evidence of a sustained clinical response to intravenous immunoglobulin. Patients were evaluated by means of the Overall Neuropathy Limitation Scale, Medical Research Council Scale and Life Quality Index questionnaire, both at the time of therapeutic shift and after 4 months of subcutaneous immunoglobulin treatment. A sustained clinical efficacy was observed after the switch to subcutaneous immunoglobulin: the Overall Neuropathy Limitation Scale score improved in the group of 66 CIDP patients (P = 0.018), with only one subject reporting a worsening of 1 point, and remained stable in the group of 21 MMN patients (P = 0.841), with one subject reporting a worsening of two points. An improvement in the patient's perception of therapeutic setting was reported in both groups. This large multi-center study confirms the short-term clinical equivalence of subcutaneous versus intravenous immunoglobulin and a possible improvement in the patient's perception of therapeutic setting with the subcutaneous administration. However, further studies are required to extend the results to a longer observational period. © 2014 Springer-Verlag Berlin Heidelberg.
2014
chronic inflammatory demyelinating polyneuropathy; inflammatory neuropathy; multifocal motor neuropathy; subcutaneous immunoglobulin; intravenous immunoglobulin
01 Pubblicazione su rivista::01a Articolo in rivista
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study / Dario, Cocito; Aristide, Merola; Erdita, Peci; Anna, Mazzeo; Raffaella, Fazio; Francia, Ada; Paola, Valentino; Rocco, Liguori; Massimiliano, Filosto; Gabriele, Siciliano; Angelo Maurizio, Clerici; Stefania, Lelli; Girolama Alessandra, Marfia; Antonini, Giovanni; Ilaria, Cecconi; Eduardo Nobile, Orazio; Leonardo, Lopiano; Italian Network Scig And chronic Dysimmune, Neuropathies. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - STAMPA. - 261:(2014), pp. 2159-2164. [10.1007/s00415-014-7444-2]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/637583
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 55
social impact